Breast Ultrasound or Thermography Are NOT Sufficient to Restart HRT
No, neither breast ultrasound nor thermography are adequate substitutes for mammography before restarting hormone replacement therapy—mammography remains the standard of care for breast cancer screening in this population. 1, 2
The Evidence Against Alternative Screening Methods
Thermography Has No Role
Thermography is explicitly not recommended for breast cancer screening. The ACR Appropriateness Criteria clearly state there is insufficient evidence to support the use of thermography for breast cancer screening 2. This is not a viable option regardless of patient preference.
Ultrasound Has Limited Utility
While breast ultrasound can be useful as a supplemental screening tool in high-risk women with dense breasts who already have mammography 2, it is not designed to replace mammography for routine screening. Ultrasound is recommended primarily:
- As an adjunct to mammography in high-risk populations
- For women who cannot undergo MRI
- For evaluating specific abnormalities found on clinical exam or mammography 1
Ultrasound alone misses cancers that mammography would detect, particularly microcalcifications that may represent ductal carcinoma in situ.
Why Mammography Matters Before HRT
Pre-Treatment Baseline is Essential
Mammography must be performed before starting or restarting HRT 3. This is critical because:
- HRT increases mammographic breast density in many women, reducing the sensitivity of future mammograms by 7-21% 4
- HRT decreases mammographic specificity by 12-50%, particularly at subsequent screenings 4
- Establishing a baseline before hormonal changes occur is essential for detecting future abnormalities
HRT and Breast Cancer Risk Context
The decision to use HRT involves understanding breast cancer risk:
- Combined estrogen-progestogen therapy carries a small, duration-dependent increase in breast cancer risk 5
- Estrogen-alone therapy (appropriate post-hysterectomy) does not increase breast cancer incidence and may reduce mortality 6, 5
- Women should use the lowest effective dose for the shortest duration 6
Addressing Patient Refusal: A Practical Algorithm
Since your patient refuses mammography, here's how to proceed:
1. Explore the Refusal
- Identify specific concerns (pain, anxiety, radiation, time)
- Address misconceptions about mammography
- Emphasize that no alternative provides equivalent cancer detection
2. Document Thoroughly
- Document the patient's informed refusal
- Document that you explained mammography is standard of care
- Document that alternatives are inadequate
3. If She Remains Adamant
You have two options:
Option A (Preferred): Delay HRT restart until mammography is completed
- Continue managing symptoms with non-hormonal approaches
- Revisit mammography discussion at follow-up
Option B (If symptoms are severely impacting quality of life):
- Consider very short-term, low-dose HRT with explicit informed consent
- Document that this is suboptimal care undertaken at patient's insistence
- Require mammography within 3-6 months as condition of continuing HRT
- Consider stopping HRT 3-6 months before eventual mammography to reduce breast density 7
Common Pitfalls to Avoid
- Do not accept ultrasound as equivalent screening—it will miss important cancers
- Do not use thermography—it has no validated role in breast cancer detection
- Do not restart HRT without addressing breast screening—you're accepting unknown baseline risk
- Do not assume post-hysterectomy status eliminates breast cancer concerns—breast tissue remains at risk
The Bottom Line
Your patient needs mammography before restarting HRT, period. Neither ultrasound nor thermography provides adequate breast cancer screening. If she absolutely refuses, you must weigh severe menopausal symptoms against unknown breast cancer risk, document extensively, and make mammography completion a non-negotiable condition for continuing therapy beyond a brief trial period.